Alteration of Intestinal Dysbiosis by Fecal Microbiota Transplantation Does not Induce Remission in Patients with Chronic Active Ulcerative Colitis
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In patients with ulcerative colitis (UC), alterations of the intestinal microbiota, termed dysbiosis, have been postulated to contribute to intestinal inflammation. Fecal microbiota transplantation (FMT) has been used as effective therapy for recurrent Clostridium difficile colitis also caused by dysbiosis. The aims of the present study were to investigate if patients with UC benefit from FMT and if dysbiosis can be reversed. METHODS: Six patients with chronic active UC nonresponsive to standard medical therapy were treated with FMT by colonoscopic administration. Changes in the colonic microbiota were assessed by 16S rDNA-based microbial community profiling using high-throughput pyrosequencing from mucosal and stool samples. RESULTS: All patients experienced short-term clinical improvement within the first 2 weeks after FMT. However, none of the patients achieved clinical remission. Microbiota profiling showed differences in the modification of the intestinal microbiota between individual patients after FMT. In 3 patients, the colonic microbiota changed toward the donor microbiota; however, this did not correlate with clinical response. On phylum level, there was a significant reduction of Proteobacteria and an increase in Bacteroidetes after FMT. CONCLUSIONS: FMT by a single colonoscopic donor stool application is not effective in inducing remission in chronic active therapy-refractory UC. Changes in the composition of the intestinal microbiota were significant and resulted in a partial improvement of UC-associated dysbiosis. The results suggest that dysbiosis in UC is at least in part a secondary phenomenon induced by inflammation and diarrhea rather than being causative for inflammation in this disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These reports were followed by a number of small studies of FMT in children and adults with UC, CD, and pouchitis with mixed results.64–72”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [69]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913 · cited 1×
“, 16S rDNA) in combination with highthroughput sequencing techniques that enabled culture-independent surveys of human gut microbes.(32) Using these techniques, remarkable changes in the human gut microbiota in patients with IBD have been observed.”
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762 · cited 1×
“5.(25) Contaminant (human) sequences and singletons were manually removed.”
BackgroundFrank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 2×
“Using these techniques, remarkable changes in the human gut microbiota in patients with IBD have been observed.(6,30,33,34) These changes, also termed dysbiosis, are thought to be involved in the pathogenesis of IBD.”
BackgroundMethodDuodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 3×
“Changes of the intestinal microbiota after FMT have so far been studied only in recurrent CDI.(13,43) Successful FMT in CDI was associated with an increase in bacterial diversity and richness,(13,43) an increase of Bacteroidetes, Firmicutes, and butyrate-producing bacteria such as Lachnospiraceae, and a decrease in Pr…”
BackgroundCoated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,026 · cited 1×
“During control visits, the clinical condition and endoscopic activity of UC were judged using the Mayo score.(20) A reduction of the total Mayo score by $3 points was considered as a clinical response, whereas a drop of the Mayo score to #2 points was considered as remission.”
MethodFord Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,020
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713
Abraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712
Kornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023 · cited 1×
“total proctocolectomy to control inflammation and complications of the disease.(7) In therapy–refractory recurrent Clostrid-”
BackgroundMicrobial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927 · cited 1×
“Finally, in advanced and long persisting UC reversal of dysbiosis and the introduction of anti-inflammatory bacteria by FMT might fail to decrease gut inflammation because of a persisting and overwhelming immune stimulation.(40) Changes of the intestinal microbiota after FMT have so far been studied only in recurrent…”
BackgroundReview and re-analysis of domain-specific 16S primers
Baker, G. C., Smith, J. J., & Cowan, D. A. (2003) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2003.08.009 · Cited by 1,865
Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples
White, J. R., Nagarajan, N., & Pop, M. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000352 · Cited by 1,586 · cited 1×
“Taxa significantly changing between time-points were assessed by Metastats using default settings.(28) For the statistical analysis and significant difference calculation, the nonparametric Wilcoxon test for dependent samples was used.”
MethodOtt, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Fölsch, U. R., Timmis, K. N., & Schreiber, S. (2004) · Gut · doi:10.1136/gut.2003.025403 · Cited by 1,311 · cited 1×
“In patients with UC, a decrease in the bacterial diversity and richness and changes in the composition of the intestinal bacteria have been reported.(30,36,37) A recent study investigating twin pairs discordant for IBD revealed a reduction in bacterial richness also in the healthy sibling mirroring the decreased richn…”
BackgroundLow counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275
Manichanh, C., Borruel, N., Casellas, F., & Guarner, F. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.152 · Cited by 1,160 · cited 15×
“epiphenomenon due to microbial alterations as a consequence of IBD.(6) The major hallmarks of UC therapy include the use of anti-inflammatory and immunosuppressant drugs(1,7); however,”
BackgroundMethodInfluentialHas the Microbiota Played a Critical Role in the Evolution of the Adaptive Immune System?
Lee, Y. K., & Mazmanian, S. K. (2010) · Science · doi:10.1126/science.1195568 · Cited by 1,121
Danese, S., & Fiocchi, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1102942 · Cited by 1,102
Kindt, R., & Coe, R. L. (2006) · Cited by 1,024
Gough, E., Shaikh, H., & Manges, A. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir632 · Cited by 1,003 · cited 3×
“A single donor stool administration has been used in most protocols for the treatment of recurrent CDI.9,11,12,14 Bennett and Brinkman15 and Borody et al16 used antibiotic pretreatment in their reported patients with UC although studies in mice showed that this may not be necessary for successful colonization of the d…”
MethodDignass, A., Eliakim, R., Magro, F., Maaser, C., Chowers, Y., Geboes, K., Mantzaris, G., Reinisch, W., Colombel, J.-F., Vermeire, S., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.003 · Cited by 888 · cited 1×
“Diagnosis of UC was established by standard clinical, endoscopic, and histologic criteria.(19) Intestinal superinfections due to C.”
MethodIBD—what role do Proteobacteria play?
Mukhopadhya, I., Hansen, R., El-Omar, E. M., & Hold, G. L. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.14 · Cited by 810 · cited 6×
“The discrepancy between correction of some prominent dysbiotic features, such as a pronounced decrease in Proteobacteria induced by FMT despite the lack of clinical efficacy in our pilot trial, is an important finding because the overabundance of Proteobacteria is the most consistent finding of dysbiosis in UC and Cro…”
BackgroundInfluentialWalker, A. W., Sanderson, J. D., Churcher, C., Parkes, G. C., Hudspith, B. N., Rayment, N., Brostoff, J., Parkhill, J., Dougan, G., & Petrovska, L. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-7 · Cited by 726 · cited 1×
“Using these techniques, remarkable changes in the human gut microbiota in patients with IBD have been observed.(6,30,33,34) These changes, also termed dysbiosis, are thought to be involved in the pathogenesis of IBD.”
MethodHigh-throughput diversity and functionality analysis of the gastrointestinal tract microbiota
Zoetendal, E. G., Rajilić-Stojanović, M., & de Vos, W. M. (2008) · Gut · doi:10.1136/gut.2007.133603 · Cited by 673 · cited 1×
“Only an estimated 10% to 20% of gut microbes can be assessed using standard cultivation techniques.(31) This challenge was overcome by PCR amplification of phylogenetic markers (e.”
BackgroundBrandt, L. J., Aroniadis, O. C., Mellow, M., Kanatzar, A., Kelly, C., Park, T., Stollman, N., Rohlke, F., & Surawicz, C. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.60 · Cited by 672 · cited 5×
“A single donor stool administration has been used in most protocols for the treatment of recurrent CDI.9,11,12,14 Bennett and Brinkman15 and Borody et al16 used antibiotic pretreatment in their reported patients with UC although studies in mice showed that this may not be necessary for successful colonization of the d…”
MethodInfluentialLepage, P., Häsler, R., Spehlmann, M. E., Rehman, A., Zvirbliene, A., Begun, A., Ott, S., Kupcinskas, L., Doré, J., Raedler, A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.011 · Cited by 597 · cited 1×
“Using these techniques, remarkable changes in the human gut microbiota in patients with IBD have been observed.(6,30,33,34) These changes, also termed dysbiosis, are thought to be involved in the pathogenesis of IBD.”
MethodStecher, B., Chaffron, S., Käppeli, R., Hapfelmeier, S., Freedrich, S., Weber, T. C., Kirundi, J., Suar, M., McCoy, K. D., von Mering, C., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000711 · Cited by 435 · cited 1×
“Studies in mice have shown that a successful intestinal colonization by pathogens but also by beneficial bacteria are linked to the presence of phylogenetically similar bacteria already present in the intestinal ecosystem.(45) It might therefore be important for successful FMT that the microbiota of the recipient cont…”
BackgroundTreatment of Ulcerative Colitis Using Fecal Bacteriotherapy
Borody, T. J., Warren, E. F., Leis, S., Surace, R., & Ashman, O. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200307000-00012 · Cited by 388 · cited 1×
“In the previously reported series, patients also had chronic active long-lasting disease, and previous therapies included immunosuppressive therapy in at least 4 of the patients; however, no patient was treated with antiTNF antibodies.(16) It remains, therefore, possible that FMT in milder forms of UC without previous…”
ResultMattila, E., Uusitalo–Seppälä, R., Wuorela, M., Lehtola, L., Nurmi, H., Ristikankare, M., Moilanen, V., Salminen, K., Seppälä, M., Mattila, P. S., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.11.037 · Cited by 371 · cited 3×
“A single donor stool administration has been used in most protocols for the treatment of recurrent CDI.9,11,12,14 Bennett and Brinkman15 and Borody et al16 used antibiotic pretreatment in their reported patients with UC although studies in mice showed that this may not be necessary for successful colonization of the d…”
MethodPROSPECTIVE DIAGNOSIS OF SPINA BIFIDA
Brock, D. J. H., Scrimgeour, J. B., Chard, T., Leek, A. E., Kitau, M. J., & Leighton, P. C. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91459-2 · Cited by 361
Watanabe, K., Kodama, Y., & Harayama, S. (2001) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(01)00220-2 · Cited by 359 · cited 1×
“com/IBD/A221).(21,22) For each sample, a PCR mix of 50 mL was prepared containing 1· Fast Start High Fidelity Buffer (Roche Diagnostics), 2.”
Method(2006) · Operative Pediatric Surgery 6Ed · doi:10.1201/b13237-67 · Cited by 341
Reshaping the gut microbiome with bacterial transplantation and antibiotic intake
Manichanh, C., Reeder, J., Gibert, P., Varela, E., Llopis, M., Antolin, M., Guigo, R., Knight, R., & Guarner, F. (2010) · Genome Research · doi:10.1101/gr.107987.110 · Cited by 335 · cited 10×
“Noteworthy, patient F showed the best clinical response to FMT.”
ResultInfluentialSystematic review: faecal microbiota transplantation in the management of inflammatory bowel disease
Anderson, J. L., Edney, R. J., & Whelan, K. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05220.x · Cited by 313
Treatment of ulcerative colitis by implantation of normal colonic flora
Bennet, J., & Brinkman, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91183-5 · Cited by 304
Alterations in the gut microbiome of children with severe ulcerative colitis
Michail, S., Durbin, M., Turner, D., Griffiths, A. M., Mack, D. R., Hyams, J., Leleiko, N., Kenche, H., Stolfi, A., & Wine, E. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22860 · Cited by 284 · cited 1×
“In patients with UC, a decrease in the bacterial diversity and richness and changes in the composition of the intestinal bacteria have been reported.(30,36,37) A recent study investigating twin pairs discordant for IBD revealed a reduction in bacterial richness also in the healthy sibling mirroring the decreased richn…”
BackgroundDamman, C. J., Miller, S. I., Surawicz, C. M., & Zisman, T. L. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.93 · Cited by 226 · cited 7×
“Nevertheless, we believe that the information gained by our data will help to better understand dysbiosis and its role in the pathogenesis of IBD because there are no other published studies investigating the effect of FMT on the intestinal microbiota in IBD.(18,46) The discrepancy between correction of some prominent…”
BackgroundMethodInfluentialBorody, T. J., George, L., Andrews, P., Brandl, S., Noonan, S., Cole, P., Hyland, L., Morgan, A., Maysey, J., & Moore‐Jones, D. (1989) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1989.tb136704.x · Cited by 221
Shahinas, D., Silverman, M., Sittler, T., Chiu, C., Kim, P., Allen-Vercoe, E., Weese, S., Wong, A., Low, D. E., & Pillai, D. R. (2012) · mBio · doi:10.1128/mbio.00338-12 · Cited by 191 · cited 4×
“Changes of the intestinal microbiota after FMT have so far been studied only in recurrent CDI.(13,43) Successful FMT in CDI was associated with an increase in bacterial diversity and richness,(13,43) an increase of Bacteroidetes, Firmicutes, and butyrate-producing bacteria such as Lachnospiraceae, and a decrease in Pr…”
BackgroundResultInfluentialKelly, C. R., de Leon, L., & Jasutkar, N. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318234570b · Cited by 190
Kaser, A., & Blumberg, R. S. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.048 · Cited by 180
Guo, B., Harstall, C., Louie, T., Veldhuyzen van Zanten, S., & Dieleman, L. A. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05033.x · Cited by 135 · cited 3×
“A single donor stool administration has been used in most protocols for the treatment of recurrent CDI.9,11,12,14 Bennett and Brinkman15 and Borody et al16 used antibiotic pretreatment in their reported patients with UC although studies in mice showed that this may not be necessary for successful colonization of the d…”
MethodAlterations in the Colonic Microbiota in Response to Osmotic Diarrhea
Gorkiewicz, G., Thallinger, G. G., Trajanoski, S., Lackner, S., Stocker, G., Hinterleitner, T., Gülly, C., & Högenauer, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055817 · Cited by 130 · cited 1×
“It still remains unclear whether the observed dysbiotic changes in the microbiota of patients with IBD are primarily responsible for the activation of the immune system and subsequent inflammation or if they rather represent a consequence of colitis and diarrhea caused by altered bacterial growth conditions.(6,41) In…”
BackgroundSelf-citationLandy, J., Al-Hassi, H. O., McLaughlin, S. D., Walker, A. W., Ciclitira, P. J., Nicholls, R. J., Clark, S. K., & Hart, A. L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04737.x · Cited by 100
The effects of commensal microbiota on immune cell subsets and inflammatory responses
Chinen, T., & Rudensky, A. Y. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01083.x · Cited by 96
Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease
De Cruz, P., Prideaux, L., Wagner, J., Ng, S. C., McSweeney, C., Kirkwood, C., Morrison, M., & Kamm, M. A. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21751 · Cited by 95
Diet promotes dysbiosis and colitis in susceptible hosts
Sartor, R. B. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.157 · Cited by 43
Research works printed but not linked: 1
- Lee, 2010, 330, 1768
Cited by
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
The gut microbiome in health and in disease
Shreiner, A. B., Kao, J. Y., & Young, V. B. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000139 · Cited by 1,682
“Early efforts to utilize FMT for the treatment of IBD have been rather disappointing [45,46].”
BackgroundDisease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease
Norman, J. M., Handley, S. A., Baldridge, M. T., Droit, L., Liu, C. Y., Keller, B. C., Kambal, A., Monaco, C. L., Zhao, G., Fleshner, P., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.002 · Cited by 1,285
“However, early attempts at curing bacterial dysbiosis in UC through fecal transplantation have not proven successful (Angelberger et al., 2013; Kump et al., 2013), perhaps due to the instability of the donor microbiome in IBD patients.”
BackgroundParamsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207
Self-citation
Metadata
- Authors
- Kump, P. K., Gröchenig, H.-P., Lackner, S., Trajanoski, S., Reicht, G., Hoffmann, K. M., Deutschmann, A., Wenzl, H. H., Petritsch, W., Krejs, G. J., Gorkiewicz, G., & Högenauer, C.
- Affiliations
- Medical University of Graz (AT)
- Hospital of the Brothers of St. John of God (AT)
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-09
- Volume
- 19
- Issue
- 10
- Pages
- 2155-2165
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W1983728610
- Cited by
- 235
- References
- 49
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 11 · 2020: 17 · 2019: 16 · 2018: 19 · 2017: 28 · 2016: 32 · 2015: 41 · 2014: 35 · 2013: 6
- FWCI
- 25.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Inflammatory Bowel Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- fecal microbiota transplantation, ulcerative colitis
- MeSH terms
- Adolescent, Adult, Biological Therapy, Chronic Disease, Clostridium Infections, Colitis, Ulcerative, Feces, Female, Follow-Up Studies, Humans, Intestines, Male, Middle Aged, Phylogeny, Prognosis, Remission Induction, RNA, Ribosomal, 16S, Transplantation, Metagenome, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.